Isotretinoin-induced inflammatory bowel disease

J L M Passier, N Srivastava, E P van Puijenbroek

    Research output: Contribution to journalArticleAcademicpeer-review

    38 Citations (Scopus)

    Abstract

    Three case reports on inflammatory bowel disease associated with use of isotretinoin are described. All three patients were male adolescents, in good health when starting isotretinoin (for acne treatment for about six months). Several weeks after discontinuation of isotretinoin the patients developed severe symptoms requiring hospitalisation. The diagnosis of ulcerative colitis was made in two of these patients, while in the third patient Crohn's disease was diagnosed. Although inflammatory bowel disease is described as an adverse drug reaction in the product information of isotretinoin, few cases have been described so far. The link with prior isotretinoin use may not be recognised by the patient or the physician, since the diagnosis of inflammatory bowel disease is often preceded by several years of vague symptoms. On the other hand, spontaneous onset of inflammatory bowel disease (not related to isotretinoin) cannot be excluded. We appeal to the readers for a reaction to this, to shed more light on the likeliness of this alleged association.

    Original languageEnglish
    Pages (from-to)52-54
    Number of pages3
    JournalThe Netherlands Journal of Medicine
    Volume64
    Issue number2
    Publication statusPublished - Feb-2006

    Keywords

    • Adolescent
    • Adult
    • Humans
    • Inflammatory Bowel Diseases
    • Isotretinoin
    • Keratolytic Agents
    • Male
    • Risk Factors

    Fingerprint

    Dive into the research topics of 'Isotretinoin-induced inflammatory bowel disease'. Together they form a unique fingerprint.

    Cite this